Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Severe deficiency of alpha-1 antitrypsin (AAT) can cause early-onset emphysema and several liver diseases, including cirrhosis, neonatal hepatitis and hepatocellular carcinoma.
This report elaborates on the current development of the Alpha 1 Antitrypsin Deficiency Treatment industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
AstraZeneca
Grifols
GlaxoSmithKline
Boehringer Ingelheim
Pfizer
Kamada Ltd
LFB Biomedicaments
CSL Behring
ProBioGen
Chiesi Pharmaceuticals
Abeona Therapeutics
Baxalta
Curaxys
Shire
ProMetic Life Sciences
Baxter
Teva Pharmaceutical Industries
By Type:
Corticosteroids
Oxygen Therapy
Bronchodilators
Augmentation Therapy
By Application:
Hospitals
Specialty Clinics
Pharmacies
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Alpha 1 Antitrypsin Deficiency Treatment Market Overview 2018-2029
-
1.1 China Alpha 1 Antitrypsin Deficiency Treatment Industry Development Overview
-
1.2 China Alpha 1 Antitrypsin Deficiency Treatment Industry Development History
-
1.3 China Alpha 1 Antitrypsin Deficiency Treatment Industry Market Size (2018-2029)
-
1.4 China Alpha 1 Antitrypsin Deficiency Treatment Market Analysis by Type from Production Side
-
1.4.1 China Alpha 1 Antitrypsin Deficiency Treatment Production Volume, Production Value and Growth Rate of Corticosteroids (2018-2029)
-
1.4.2 China Alpha 1 Antitrypsin Deficiency Treatment Production Volume, Production Value and Growth Rate of Oxygen Therapy (2018-2029)
-
1.4.3 China Alpha 1 Antitrypsin Deficiency Treatment Production Volume, Production Value and Growth Rate of Bronchodilators (2018-2029)
-
1.4.4 China Alpha 1 Antitrypsin Deficiency Treatment Production Volume, Production Value and Growth Rate of Augmentation Therapy (2018-2029)
-
1.5 China Alpha 1 Antitrypsin Deficiency Treatment Market Analysis by Application from Consumption End
-
1.5.1 China Alpha 1 Antitrypsin Deficiency Treatment Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)
-
1.5.2 China Alpha 1 Antitrypsin Deficiency Treatment Sales Volume, Sales Value and Growth Rate of Specialty Clinics (2018-2029)
-
1.5.3 China Alpha 1 Antitrypsin Deficiency Treatment Sales Volume, Sales Value and Growth Rate of Pharmacies (2018-2029)
-
1.6 China Alpha 1 Antitrypsin Deficiency Treatment Market Analysis by Region
-
1.6.1 North China Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2018-2029
Chapter 2 China Alpha 1 Antitrypsin Deficiency Treatment Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Alpha 1 Antitrypsin Deficiency Treatment Market Status and Competition at home and abroad in 2023
-
2.2.2 China Alpha 1 Antitrypsin Deficiency Treatment Market Status and Competition Analysis in 2023
-
2.2.3 China Alpha 1 Antitrypsin Deficiency Treatment Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Alpha 1 Antitrypsin Deficiency Treatment Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Alpha 1 Antitrypsin Deficiency Treatment Industry Development
Chapter 3 Alpha 1 Antitrypsin Deficiency TreatmentIndustry Chain Analysis
-
3.1 Alpha 1 Antitrypsin Deficiency Treatment Industry Chain
-
3.2 Alpha 1 Antitrypsin Deficiency Treatment Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Alpha 1 Antitrypsin Deficiency Treatment Market
-
3.3 Alpha 1 Antitrypsin Deficiency Treatment Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Alpha 1 Antitrypsin Deficiency Treatment Market
Chapter 4 China Alpha 1 Antitrypsin Deficiency Treatment Market, by Type
-
4.1 China Alpha 1 Antitrypsin Deficiency Treatment Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Alpha 1 Antitrypsin Deficiency Treatment Total Production Volume and Growth Rate from Production Side
-
4.5 China Alpha 1 Antitrypsin Deficiency Treatment Production Volume and Growth Rate, by Type
-
4.5.1 China Alpha 1 Antitrypsin Deficiency Treatment Production Volume and Growth Rate of Corticosteroids
-
4.5.2 China Alpha 1 Antitrypsin Deficiency Treatment Production Volume and Growth Rate of Oxygen Therapy
-
4.5.3 China Alpha 1 Antitrypsin Deficiency Treatment Production Volume and Growth Rate of Bronchodilators
-
4.5.4 China Alpha 1 Antitrypsin Deficiency Treatment Production Volume and Growth Rate of Augmentation Therapy
Chapter 5 China Alpha 1 Antitrypsin Deficiency Treatment Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Alpha 1 Antitrypsin Deficiency Treatment Total Market Size and Growth Rate from Consumption End
-
5.5 China Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate, by Application
-
5.5.1 China Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate of Hospitals
-
5.5.2 China Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate of Specialty Clinics
-
5.5.3 China Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate of Pharmacies
Chapter 6 China Alpha 1 Antitrypsin Deficiency Treatment Market, by Region
-
6.1 China Alpha 1 Antitrypsin Deficiency Treatment Production Volume and Production Value, by Region
-
6.2 China Alpha 1 Antitrypsin Deficiency Treatment Sales Volume and Sales Value, by Region
Chapter 7 North China Alpha 1 Antitrypsin Deficiency Treatment Market Analysis
-
7.1 North China Alpha 1 Antitrypsin Deficiency Treatment Market, by Type
-
7.2 North China Alpha 1 Antitrypsin Deficiency Treatment Market, by Application
Chapter 8 Central China Alpha 1 Antitrypsin Deficiency Treatment Market Analysis
-
8.1 Central China Alpha 1 Antitrypsin Deficiency Treatment Market, by Type
-
8.2 Central China Alpha 1 Antitrypsin Deficiency Treatment Market, by Application
Chapter 9 South China Alpha 1 Antitrypsin Deficiency Treatment Market Analysis
-
9.1 South China Alpha 1 Antitrypsin Deficiency Treatment Market, by Type
-
9.2 South China Alpha 1 Antitrypsin Deficiency Treatment Market, by Application
Chapter 10 East China Alpha 1 Antitrypsin Deficiency Treatment Market Analysis
-
10.1 East China Alpha 1 Antitrypsin Deficiency Treatment Market, by Type
-
10.2 East China Alpha 1 Antitrypsin Deficiency Treatment Market, by Application
Chapter 11 Northeast China Alpha 1 Antitrypsin Deficiency Treatment Market Analysis
-
11.1 Northeast China Alpha 1 Antitrypsin Deficiency Treatment Market, by Type
-
11.2 Northeast China Alpha 1 Antitrypsin Deficiency Treatment Market, by Application
Chapter 12 Southwest China Alpha 1 Antitrypsin Deficiency Treatment Market Analysis
-
12.1 Southwest China Alpha 1 Antitrypsin Deficiency Treatment Market, by Type
-
12.2 Southwest China Alpha 1 Antitrypsin Deficiency Treatment Market, by Application
Chapter 13 Northwest China Alpha 1 Antitrypsin Deficiency Treatment Market Analysis
-
13.1 Northwest China Alpha 1 Antitrypsin Deficiency Treatment Market, by Type
-
13.2 Northwest China Alpha 1 Antitrypsin Deficiency Treatment Market, by Application
Chapter 14 Company Profiles
-
14.1 AstraZeneca
-
14.1.1 AstraZeneca Company Profile
-
14.1.2 AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Grifols
-
14.2.1 Grifols Company Profile
-
14.2.2 Grifols Alpha 1 Antitrypsin Deficiency Treatment Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 GlaxoSmithKline
-
14.3.1 GlaxoSmithKline Company Profile
-
14.3.2 GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Boehringer Ingelheim
-
14.4.1 Boehringer Ingelheim Company Profile
-
14.4.2 Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Pfizer
-
14.5.1 Pfizer Company Profile
-
14.5.2 Pfizer Alpha 1 Antitrypsin Deficiency Treatment Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Kamada Ltd
-
14.6.1 Kamada Ltd Company Profile
-
14.6.2 Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 LFB Biomedicaments
-
14.7.1 LFB Biomedicaments Company Profile
-
14.7.2 LFB Biomedicaments Alpha 1 Antitrypsin Deficiency Treatment Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 CSL Behring
-
14.8.1 CSL Behring Company Profile
-
14.8.2 CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 ProBioGen
-
14.9.1 ProBioGen Company Profile
-
14.9.2 ProBioGen Alpha 1 Antitrypsin Deficiency Treatment Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Chiesi Pharmaceuticals
-
14.10.1 Chiesi Pharmaceuticals Company Profile
-
14.10.2 Chiesi Pharmaceuticals Alpha 1 Antitrypsin Deficiency Treatment Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Abeona Therapeutics
-
14.11.1 Abeona Therapeutics Company Profile
-
14.11.2 Abeona Therapeutics Alpha 1 Antitrypsin Deficiency Treatment Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Baxalta
-
14.12.1 Baxalta Company Profile
-
14.12.2 Baxalta Alpha 1 Antitrypsin Deficiency Treatment Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 Curaxys
-
14.13.1 Curaxys Company Profile
-
14.13.2 Curaxys Alpha 1 Antitrypsin Deficiency Treatment Market Performance
-
14.13.3 Product&Service Introduction
-
14.14 Shire
-
14.14.1 Shire Company Profile
-
14.14.2 Shire Alpha 1 Antitrypsin Deficiency Treatment Market Performance
-
14.14.3 Product&Service Introduction
-
14.15 ProMetic Life Sciences
-
14.15.1 ProMetic Life Sciences Company Profile
-
14.15.2 ProMetic Life Sciences Alpha 1 Antitrypsin Deficiency Treatment Market Performance
-
14.15.3 Product&Service Introduction
-
14.16 Baxter
-
14.16.1 Baxter Company Profile
-
14.16.2 Baxter Alpha 1 Antitrypsin Deficiency Treatment Market Performance
-
14.16.3 Product&Service Introduction
-
14.17 Teva Pharmaceutical Industries
-
14.17.1 Teva Pharmaceutical Industries Company Profile
-
14.17.2 Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Market Performance
-
14.17.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Alpha 1 Antitrypsin Deficiency Treatment Industry Research Conclusions
-
15.2 Alpha 1 Antitrypsin Deficiency Treatment Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Alpha 1 Antitrypsin Deficiency Treatment Industry Market Size (2018-2029)
-
Figure China Alpha 1 Antitrypsin Deficiency Treatment Production Volume, Production Value and Growth Rate of Corticosteroids (2018-2029)
-
Figure China Alpha 1 Antitrypsin Deficiency Treatment Production Volume, Production Value and Growth Rate of Oxygen Therapy (2018-2029)
-
Figure China Alpha 1 Antitrypsin Deficiency Treatment Production Volume, Production Value and Growth Rate of Bronchodilators (2018-2029)
-
Figure China Alpha 1 Antitrypsin Deficiency Treatment Production Volume, Production Value and Growth Rate of Augmentation Therapy (2018-2029)
-
Figure China Alpha 1 Antitrypsin Deficiency Treatment Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)
-
Figure China Alpha 1 Antitrypsin Deficiency Treatment Sales Volume, Sales Value and Growth Rate of Specialty Clinics (2018-2029)
-
Figure China Alpha 1 Antitrypsin Deficiency Treatment Sales Volume, Sales Value and Growth Rate of Pharmacies (2018-2029)
-
Figure North China Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2018-2029
-
Figure Central China Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2018-2029
-
Figure South China Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2018-2029
-
Figure East China Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2018-2029
-
Figure Alpha 1 Antitrypsin Deficiency Treatment Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Alpha 1 Antitrypsin Deficiency Treatment Market Share by Type in 2018
-
Figure China Alpha 1 Antitrypsin Deficiency Treatment Market Share by Type in 2023
-
Figure China Alpha 1 Antitrypsin Deficiency Treatment Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Alpha 1 Antitrypsin Deficiency Treatment Production Volume and Growth Rate of Corticosteroids (2018-2023)
-
Figure China Alpha 1 Antitrypsin Deficiency Treatment Production Volume and Growth Rate of Oxygen Therapy (2018-2023)
-
Figure China Alpha 1 Antitrypsin Deficiency Treatment Production Volume and Growth Rate of Bronchodilators (2018-2023)
-
Figure China Alpha 1 Antitrypsin Deficiency Treatment Production Volume and Growth Rate of Augmentation Therapy (2018-2023)
-
Figure China Alpha 1 Antitrypsin Deficiency Treatment Market Share by Application in 2018
-
Figure China Alpha 1 Antitrypsin Deficiency Treatment Market Share by Application in 2023
-
Figure China Alpha 1 Antitrypsin Deficiency Treatment Total Market Size and Growth Rate from Consumption End
-
Figure China Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate of Hospitals (2018-2023)
-
Figure China Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate of Specialty Clinics (2018-2023)
-
Figure China Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate of Pharmacies (2018-2023)
-
Table China Alpha 1 Antitrypsin Deficiency Treatment Production Volume by Region (2018-2023)
-
Table China Alpha 1 Antitrypsin Deficiency Treatment Production Volume Share by Region (2018-2023)
-
Figure China Alpha 1 Antitrypsin Deficiency Treatment Production Volume Share by Region (2018-2023)
-
Table China Alpha 1 Antitrypsin Deficiency Treatment Production Value by Region (2018-2023)
-
Table China Alpha 1 Antitrypsin Deficiency Treatment Production Value Share by Region (2018-2023)
-
Figure China Alpha 1 Antitrypsin Deficiency Treatment Production Value Share by Region (2018-2023)
-
Table China Alpha 1 Antitrypsin Deficiency Treatment Sales Volume by Region (2018-2023)
-
Table China Alpha 1 Antitrypsin Deficiency Treatment Sales Volume Share by Region (2018-2023)
-
Figure China Alpha 1 Antitrypsin Deficiency Treatment Sales Volume Share by Region (2018-2023)
-
Table China Alpha 1 Antitrypsin Deficiency Treatment Sales Value by Region (2018-2023)
-
Table China Alpha 1 Antitrypsin Deficiency Treatment Sales Value Share by Region (2018-2023)
-
Figure China Alpha 1 Antitrypsin Deficiency Treatment Sales Value Share by Region (2018-2023)
-
Table North China Alpha 1 Antitrypsin Deficiency Treatment Production Volume by Type (2018-2023)
-
Table North China Alpha 1 Antitrypsin Deficiency Treatment Production Volume Share by Type (2018-2023)
-
Figure North China Alpha 1 Antitrypsin Deficiency Treatment Production Volume Share by Type (2018-2023)
-
Table North China Alpha 1 Antitrypsin Deficiency Treatment Sales Volume by Application (2018-2023)
-
Table North China Alpha 1 Antitrypsin Deficiency Treatment Sales Volume Share by Application (2018-2023)
-
Figure North China Alpha 1 Antitrypsin Deficiency Treatment Sales Volume Share by Application (2018-2023)
-
Table Central China Alpha 1 Antitrypsin Deficiency Treatment Production Volume by Type (2018-2023)
-
Table Central China Alpha 1 Antitrypsin Deficiency Treatment Production Volume Share by Type (2018-2023)
-
Figure Central China Alpha 1 Antitrypsin Deficiency Treatment Production Volume Share by Type (2018-2023)
-
Table Central China Alpha 1 Antitrypsin Deficiency Treatment Sales Volume by Application (2018-2023)
-
Table Central China Alpha 1 Antitrypsin Deficiency Treatment Sales Volume Share by Application (2018-2023)
-
Figure Central China Alpha 1 Antitrypsin Deficiency Treatment Sales Volume Share by Application (2018-2023)
-
Table South China Alpha 1 Antitrypsin Deficiency Treatment Production Volume by Type (2018-2023)
-
Table South China Alpha 1 Antitrypsin Deficiency Treatment Production Volume Share by Type (2018-2023)
-
Figure South China Alpha 1 Antitrypsin Deficiency Treatment Production Volume Share by Type (2018-2023)
-
Table South China Alpha 1 Antitrypsin Deficiency Treatment Sales Volume by Application (2018-2023)
-
Table South China Alpha 1 Antitrypsin Deficiency Treatment Sales Volume Share by Application (2018-2023)
-
Figure South China Alpha 1 Antitrypsin Deficiency Treatment Sales Volume Share by Application (2018-2023)
-
Table East China Alpha 1 Antitrypsin Deficiency Treatment Production Volume by Type (2018-2023)
-
Table East China Alpha 1 Antitrypsin Deficiency Treatment Production Volume Share by Type (2018-2023)
-
Figure East China Alpha 1 Antitrypsin Deficiency Treatment Production Volume Share by Type (2018-2023)
-
Table East China Alpha 1 Antitrypsin Deficiency Treatment Sales Volume by Application (2018-2023)
-
Table East China Alpha 1 Antitrypsin Deficiency Treatment Sales Volume Share by Application (2018-2023)
-
Figure East China Alpha 1 Antitrypsin Deficiency Treatment Sales Volume Share by Application (2018-2023)
-
Table Northeast China Alpha 1 Antitrypsin Deficiency Treatment Production Volume by Type (2018-2023)
-
Table Northeast China Alpha 1 Antitrypsin Deficiency Treatment Production Volume Share by Type (2018-2023)
-
Figure Northeast China Alpha 1 Antitrypsin Deficiency Treatment Production Volume Share by Type (2018-2023)
-
Table Northeast China Alpha 1 Antitrypsin Deficiency Treatment Sales Volume by Application (2018-2023)
-
Table Northeast China Alpha 1 Antitrypsin Deficiency Treatment Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Alpha 1 Antitrypsin Deficiency Treatment Sales Volume Share by Application (2018-2023)
-
Table Southwest China Alpha 1 Antitrypsin Deficiency Treatment Production Volume by Type (2018-2023)
-
Table Southwest China Alpha 1 Antitrypsin Deficiency Treatment Production Volume Share by Type (2018-2023)
-
Figure Southwest China Alpha 1 Antitrypsin Deficiency Treatment Production Volume Share by Type (2018-2023)
-
Table Southwest China Alpha 1 Antitrypsin Deficiency Treatment Sales Volume by Application (2018-2023)
-
Table Southwest China Alpha 1 Antitrypsin Deficiency Treatment Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Alpha 1 Antitrypsin Deficiency Treatment Sales Volume Share by Application (2018-2023)
-
Table Northwest China Alpha 1 Antitrypsin Deficiency Treatment Production Volume by Type (2018-2023)
-
Table Northwest China Alpha 1 Antitrypsin Deficiency Treatment Production Volume Share by Type (2018-2023)
-
Figure Northwest China Alpha 1 Antitrypsin Deficiency Treatment Production Volume Share by Type (2018-2023)
-
Table Northwest China Alpha 1 Antitrypsin Deficiency Treatment Sales Volume by Application (2018-2023)
-
Table Northwest China Alpha 1 Antitrypsin Deficiency Treatment Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Alpha 1 Antitrypsin Deficiency Treatment Sales Volume Share by Application (2018-2023)
-
Table AstraZeneca Company Profile
-
Table AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Revenue, Price and Gross (2018-2023)
-
Table Grifols Company Profile
-
Table Grifols Alpha 1 Antitrypsin Deficiency Treatment Revenue, Price and Gross (2018-2023)
-
Table GlaxoSmithKline Company Profile
-
Table GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Revenue, Price and Gross (2018-2023)
-
Table Boehringer Ingelheim Company Profile
-
Table Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Revenue, Price and Gross (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Alpha 1 Antitrypsin Deficiency Treatment Revenue, Price and Gross (2018-2023)
-
Table Kamada Ltd Company Profile
-
Table Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Revenue, Price and Gross (2018-2023)
-
Table LFB Biomedicaments Company Profile
-
Table LFB Biomedicaments Alpha 1 Antitrypsin Deficiency Treatment Revenue, Price and Gross (2018-2023)
-
Table CSL Behring Company Profile
-
Table CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Revenue, Price and Gross (2018-2023)
-
Table ProBioGen Company Profile
-
Table ProBioGen Alpha 1 Antitrypsin Deficiency Treatment Revenue, Price and Gross (2018-2023)
-
Table Chiesi Pharmaceuticals Company Profile
-
Table Chiesi Pharmaceuticals Alpha 1 Antitrypsin Deficiency Treatment Revenue, Price and Gross (2018-2023)
-
Table Abeona Therapeutics Company Profile
-
Table Abeona Therapeutics Alpha 1 Antitrypsin Deficiency Treatment Revenue, Price and Gross (2018-2023)
-
Table Baxalta Company Profile
-
Table Baxalta Alpha 1 Antitrypsin Deficiency Treatment Revenue, Price and Gross (2018-2023)
-
Table Curaxys Company Profile
-
Table Curaxys Alpha 1 Antitrypsin Deficiency Treatment Revenue, Price and Gross (2018-2023)
-
Table Shire Company Profile
-
Table Shire Alpha 1 Antitrypsin Deficiency Treatment Revenue, Price and Gross (2018-2023)
-
Table ProMetic Life Sciences Company Profile
-
Table ProMetic Life Sciences Alpha 1 Antitrypsin Deficiency Treatment Revenue, Price and Gross (2018-2023)
-
Table Baxter Company Profile
-
Table Baxter Alpha 1 Antitrypsin Deficiency Treatment Revenue, Price and Gross (2018-2023)
-
Table Teva Pharmaceutical Industries Company Profile
-
Table Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Revenue, Price and Gross (2018-2023)
-
